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settings will result in data which has been inﬂuenced by differ-
ences in interpretation of the scale, providing support for the
FDA’s perspective that VAS can provide a ‘false sense of preci-
sion’. This has implications for international clinical trials in
which data pooling is required. This study allowed for a critical
appraisal of the VAS response format which will assist in the
collection of more valid data in multinational studies.
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OBJECTIVE: In contrast to effectiveness of health care interven-
tions, health states preferences might not be transferable between
countries. A frequently used instrument to measure health-
related quality of life is the EQ-5D, which has been developed to
compare preferences across countries. Although the impact of
using any of the ﬁfteen national EQ-5D value sets on utility
estimates is known, the impact on the incremental utility is
unknown so far. METHODS: First, the relative inﬂuence of the
EQ-5D domains on the utility estimate was assessed for each of
the ﬁfteen currently existing value sets. Second, two health states
(21232 and 33321) were selected for further analyses. With the
help of the two hypothetical health states we determined the
inﬂuence of one or two point deteriorations of the health states.
Based on this, the ﬁfteen value sets were used to calculate incre-
mental utility scores. RESULTS: Differences can be perceived
between the value sets and between the valuation methods in the
preferences for the domains of the EQ-5D. The utility scores of
health states show that the differences between the value sets are
substantial. Next to that, the dissimilarities between the incre-
ments of the deteriorations of the health sets are large, indepen-
dent of which valuation method is used. CONCLUSION: All
results indicate that the differences between the value sets are
considerable and should not be ignored. The magnitudes of the
coefﬁcients of the domains vary in a great extent, which causes
dissimilarities when calculating the incremental utilities. As a
consequence it can be concluded that the utility scores are not
transferable across countries.
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OBJECTIVES: No measures of health-related absenteeism and
presenteeism have been validated for use in French-speaking
Canada. It is important to understand how illness affects an
employee’s productivity and therefore an organization’s proﬁt-
ability; when ill, an employee may take a sick day (absenteeism)
or attend work despite the illness and experience a loss of work
efﬁciency (presenteeism). The WPAI-GH, a leading measure of
these work productivity indicators, has not yet been tested in
French Canada to test for both clarity of translation and item
comprehension. Before using a French translation of an available
English-language questionnaire, the linguistic validity of this new
version must be established to ensure its conceptual equivalence
to the original as well as its cultural appropriateness. The objec-
tive of this study was to evaluate the linguistic validity of the
Canadian French version of the Work Productivity and Activity
Impairment questionnaire, General Health Version (WPAI:GH).
METHODS: A Canadian French translation of the US English
WPAI:GH was created through a reiterative process of creating
harmonized forward and back translations by independent
translators. French-speaking subjects residing in Canada self-
administered the WPAI:GH and were subsequently debriefed by
a bilingual (French-English) interviewer. RESULTS: Thirty
French-Canadian subjects were interviewed, all of whom were
currently employed at the time of the interview. The group was
stratiﬁed by educational level, including an equal number of
participants both with and without a high school degree. The
WPAI:GH item comprehension rate was 97.2%; no response
revisions were offered by any of the subjects. Responses to hypo-
thetical scenarios indicated that the French for Canada language
version adequately differentiates sick time taken for health and
non-health reasons and between absenteeism and presenteeism.
CONCLUSIONS: Linguistic validity of the French for Canada
translation of the WPAI:GH was established among a diverse
French Canadian population, including those with minimal
education.
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OBJECTIVES: In economic evaluation it is often assumed that
utility is a linear function of lifetime. The aim of this study was
ﬁrst to test the assumption of linearity, for short increases in
longevity, and second to test whether there exists a minimum
threshold below which life extensions are not utility bearing.
METHODS: A representative sample of the population
(n = 2,400) was asked to imagine that they had a limited remain-
ing lifetime (1 year or 10 years) and were offered a treatment that
would increase lifetime by 1, 2, 4, 8, 16, 32 weeks (1 year
perspective) or 2, 3, 8, 12, 32 or 52 weeks (10 years perspective).
In each perspective, the price of treatment was constant per week
life extension (i.e. constant proportions of acceptance across
formats would indicate a linear utility function). Additionally,
respondents were asked about their maximum willingness-to-pay
(WTP) for the life extension. RESULTS: The proportions that
accepted the treatment offer to the given price increased with
increasing extensions (1 year: 48%, 54%, 55%, 59%, 59%,
61%; 10 years: 55%, 60%, 62%, 66%, 65%, 76%) indicating a
convex utility function. In maximum WTP, the groups of respon-
dents with increasing and diminishing marginal utility functions
were of similar sizes. The proportions with zero WTP for the
treatment declined from 34% for one week life extension to 14%
for 52 weeks. The results were conﬁrmed in various econometric
models. CONCLUSIONS: While most health care programmes
offer life extensions of less than one year, considerable propor-
tions of the population may be unwilling to pay anything for
such gains. For life extensions up to one year, most of the results
indicate an increasing marginal utility function for lifetime.
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OBJECTIVES: Systematic reviews have become increasingly
important in recent years, particularly to inform the inclusion of
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